Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3358 Target Snapshot

Amine oxidase [flavin-containing] A · SINGLE PROTEIN · Rattus norvegicus

1,662Compounds
333Assays
18Approved Drugs
1,475.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P21396. Use UniProt P21396 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P21396 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Amine oxidase [flavin-containing] A as ChEMBL target CHEMBL3358, mapped to UniProt P21396. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Amine oxidase [flavin-containing] A
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3358
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P21396
Amine oxidase [flavin-containing] A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Amine oxidase [flavin-containing] A is the right protein anchor across sources, using UniProt P21396 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAmine oxidase [flavin-containing] A
UniProt AccessionP21396
Component TypeProtein
Sequence Length526 aa

Amine oxidase [flavin-containing] A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Amine oxidase [flavin-containing] A, mapped to UniProt P21396. Sequence length is 526 aa.

Mapped IDP21396
Review nameAmine oxidase [flavin-containing] A
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

18
Approved
11
Phase II
Assay Mix

Activity Type Distribution

IC501,228.0
KI246.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL298006 9.52 Ki 0.3 Preclinical
CHEMBL8706 9.38 IC50 0.42 Clinical
CHEMBL2022927 9.1 IC50 0.79 Preclinical
CHEMBL46952 9.1 Ki 0.8 Preclinical
CHEMBL54762 9.0 IC50 1.0 Preclinical
CHEMBL887 9.0 IC50 1.0 Approved
CHEMBL206465 8.89 IC50 1.3 Preclinical
CHEMBL44433 8.85 Ki 1.4 Preclinical
CHEMBL3415613 8.82 IC50 1.5 Preclinical
CHEMBL46898 8.82 Ki 1.5 Preclinical
Distribution

pChEMBL Value Distribution

170
5.0
119
5.5
142
6.0
83
6.5
113
7.0
45
7.5
56
8.0
21
8.5
6
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

RASAGILINE
CHEMBL887
Approved 2005
RASAGILINE MESYLATE
CHEMBL1201142
Approved 2005
TACRINE
CHEMBL95
Approved 1993
MOCLOBEMIDE
CHEMBL86304
Approved 1990
SELEGILINE
CHEMBL972
Approved 1989
SELEGILINE HYDROCHLORIDE
CHEMBL1200904
Approved 1989
TOLOXATONE
CHEMBL18116
Approved 1984
PHENELZINE
CHEMBL1089
Approved 1961
Assay Landscape

Assay Landscape

333
Total Assays
1,062
Tested Compounds
4
Assay Types
Binding — 313 assays, 1,062 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 123 341 5.7
assay format 81 306 6.2
single protein format 71 233 6.0
mitochondrion format 23 161 5.4
organism-based format 8 2 7.8
cell membrane format 4 11 4.9
cell-based format 2 7 5.2
subcellular format 1 1 8.1
Functional — 18 assays, 3 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 12 0
assay format 4 3 6.0
tissue-based format 2 0
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 0
Toxicity — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 7.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine